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The population demographic of Australia has 
undergone recent change. Between 1985 to 2005, the 
population above the age of 65 years increased from 
10% to 13% and those above 85 years has increased 
from less than 1% in 1984 to 1.5% in 20041. As the 
elderly live longer, they will be exposed to an increase 
in risk of trauma. This being said, trauma remains an 
uncommon cause of death in the elderly. According 
to the Australian Bureau of Statistics, in 2004 trauma 
as a cause of death (categorised within external 
causes of morbidity and mortality) in those aged 
between 75 to 84 years was ranked eighth and ninth 
amongst males and females respectively2. However, 
the impact of trauma upon the elderly is substantial. 
The recently published National Trauma Registry 
(Australia and New Zealand) revealed highest 
mortality in elderly trauma patients: of those aged 
65 to 74 years, 79.9% survived to hospital discharge; 
those aged 75 to 84 years, 71% survived to discharge; 
and those above 85 years only 64% survived to 
discharge3. 
Reports detailing mortality and functional out-
comes of hospitalised elderly trauma patients from 
the USA, Canada and Europe concluded that age, 
associated comorbidities and injury severity predict 
prolonged intensive care unit (ICU) stay and 
increased mortality in hospital and after discharge4-8. 
Some data are available with respect to the Australian 
experience, but none specifically on the cost of 
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SUMMARY
Mortality and cost outcomes of elderly intensive care unit (ICU) trauma patients were characterised in a 
retrospective cohort study from an Australian tertiary ICU. Trauma patients admitted between January 2000 and 
December 2005 were grouped into three major age categories: aged ≥65 years admitted into ICU (n=272); aged 
≥65 years admitted into general ward (n=610) and aged <65 years admitted into ICU (n=1617). Hospital 
mortality predictors were characterised as odds ratios (OR) using logistic regression. The impact of predictor 
variables on (log) total hospital-stay costs was determined using least squares regression. An alternate treatment-
effects regression model estimated the mortality cost-effect as an endogenous variable. Mortality predictors 
(P ≤0.0001, comparator: ICU ≥65 years, ventilated) were: ICU <65 not-ventilated (OR 0.014); ICU <65 
ventilated (OR 0.090); ICU age ≥65 not-ventilated (OR 0.061) and ward ≥65 (OR 0.086); increasing injury 
severity score and increased Charlson comorbidity index of 1 and 2, compared with zero (OR 2.21 [1.40 to 3.48] and 
OR 2.57 [1.45 to 4.55]). The raw mean daily ICU and hospital costs in A$ 2005 (US$) for age <65 and ≥65 to 
ICU, and≥65 to the ward were; for year 2000: ICU, $2717 (1462) and $2777 (1494); hospital, $1837 (988) and 
$1590 (855); ward $933 (502); for year 2005: ICU, $3202 (2393) and $3086 (2307); hospital, $1938 (1449) and 
$1914 (1431); ward $1180 (882). Cost increments were predicted by age ≥65 and ICU admission, increasing injury 
severity score, mechanical ventilation, Charlson comorbidity index increments and hospital survival. Mortality 
cost-effect was estimated at -63% by least squares regression and -82% by treatment-effects regression model. 
Patient demographic factors, injury severity and its consequences predict both cost and survival in trauma. The cost 
mortality effect was biased upwards by conventional least squares regression estimation.
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treatment of the ICU elderly trauma cohort. A 
recent retrospective analysis of data by Lee et al 
showed that in-hospital mortality rate of the elderly 
(defined as above 65 years) was twice that of 
younger patients; the elderly also had significantly 
higher rates of chest injuries that demanded a longer 
ICU stay9. A retrospective study on elderly trauma 
by Day et al found that age was an important factor 
in survival, but that survivors had good functional 
recovery10. The purpose of this study was to 
characterise: 1) the hospital mortality, and its 
determinants, of elderly trauma patients admitted to 
an Australian tertiary ICU and high dependency unit 
(HDU) and 2) the treatment cost of these patients 
allowing for the heterogeneous costing methodology 
that has been applied in intensive care setting11,12. 
METHoDS
Setting
This was a retrospective cohort study conducted 
at a major adult tertiary care trauma centre of South 
Australia (Royal Adelaide Hospital [RAH]). The 
hospital provides services in all the major medical 
and surgical specialties. The ICU is a mixed 24-bed 
medical and surgical unit, with an additional 10 HDU 
beds. The study was approved by the RAH Human 
Research Ethics Committee.
Patients
The RAH electronic trauma registry was examined 
for the period of January 2000 to December 2005. 
Patients entered into the trauma registry fulfilled 
the following criteria: all patients admitted to the 
hospital who had sustained injury(ies) falling within 
the ICD9-CM code range 800.0 to 959.9 as a result 
of a traumatic event (ICD10-AM code range S00-T98 
excluding poisoning from 1 July 2000) and
died within the emergency department, or •
were admitted to ICU/HDU, or  •
had an injury severity score (ISS) >16, or •
patients to whom the trauma team was called, or •
patients who were retrieved (by the RAH Medi- •
flight Medical Team from South Australia and 
interstate).
Identified trauma patients were grouped into three 
major age categories: aged ≥65 years admitted into 
ICU/HDU; aged ≥65 years admitted into general 
ward and aged <65 years admitted into ICU/HDU. 
Elderly patients were defined as age of ≥65 years3,9.
Data collection
The following data were obtained for all patients: 
age, gender, ISS, duration of ventilation (in hours), 
length of ICU and hospital stay (days), the Charlson 
comorbidity index (CCI) and outcome at hospital 
discharge (dead or alive). The CCI, which measures 
the underlying severity of comorbid illness, scores 
from 1 to 6 for 19 specific medical diagnoses, 
representing increasing levels of illness13. The CCI 
was computed by examination of the electronic 
administrative data listings for the ICD-10 codes 
of each patient and subsequent processing by the 
Stata™ module “Charlson”14,15. Binary (scored 0,1) 
categorical variables were generated to reflect patient 
admission on Saturday or Sunday (“weekend”), 
admission between 1800 and 0600 hours the following 
day (“after-hours”) and after-hours not at the 
weekend (“afterhours-weekday”). Acute physio- 
logical and chronic health evaluation scores were 
unable to be utilised due to incomplete data 
collection.
Information on the cost of hospital stay (≡total 
costs) of the patients was gathered from the RAH 
Finance Department, Case Mix and Clinical Costing 
Unit. The sum total costs consisted of the drug, 
medical/surgical, prosthesis, operating theatre and 
recovery, allied health, pathology, imaging, ICU, 
medical salaries/wages, nursing salaries/wages, 
indirect overhead and miscellaneous costs (see 
Appendix 2 on the online version).
South Australian health consumer price indices 
(CPI)16 and Australian versus US dollar yearly 
average exchange rates17 over the time of the 
study were obtained from the Australian Bureau 
of Statistics. Yearly health CPIs were (2000 to 
2005): 167.6, 169.3, 178.1, 193.3, 204.8 and 214.4 
respectively; yearly average exchange rates were 
(2000 to 2005): 0.5379, 0.5239, 0.5848, 0.7137, 0.7529 
and 0.7474 respectively.
Statistical analysis
Variables were reported as mean (SD) unless 
otherwise indicated. Pearson’s chi-squared was used 
for the categorical variables and analysis of variance 
was performed by the kruskal-Wallis non-parametric 
test; for summarising raw variable time-change, 
simple non-parametric trend tests were used. 
Distributions of variables of interest were visualised 
by trellis plots, based on a formula with the structure 
y~x  a×b, where y is a continuous or factor variable, 
x is continuous, and a and b are factors18.
Hospital mortality was modelled using logistic 
regression. ISS and calendar year were considered 
as continuous variables and candidate categorical 
predictors were parameterised as simple 
indicator variables. Non-linear variable effect 
was demonstrated using fractional polynomials19. 
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Clinically meaningful combinations of variables and 
their (two-way) interactions were assessed for effect 
in the logistic model20; model adequacy was gauged 
by the traditional criteria of discrimination (receiver 
operating characteristic [RoC] area) and calibration 
(Hosmer-Lemeshow [H-LĈ] statistic)21. The final 
model was developed on training (75% of data) 
and determination sets (25% of data); the random 
samples being stratified by calendar year. The model 
chi-squared was calculated for each parameter to 
adjudge the relative ‘importance’ of the parameter22.
The total cost of care and the mean daily cost of 
care (over the period of stay in ICU and hospital) 
were calculated; this was expressed as either costs 
per current year or adjusted23 by health CPI to 2005 
Australian dollars, as indicated in the text. Cost 
predictors for total hospital costs (as A$ 2005) were 
determined by ordinary least squares regression 
analysis using log transformed costs and comparison 
with a raw-cost regression model was also under-
taken (including the concordance of predicted and 
raw cost24). Final R2, as the squared correlation of 
predicted versus raw costs, was reported on the 
back-transformed ‘dollar’ scale, as the expectation 
was that regression with log transformed dependent 
variable would yield a higher R2 than using raw 
costs25. Stability of both the mortality cost model 
was determined by a split-sample technique (75% 
determination, 25% validation sub-sets); overall 
model parsimony was sought. 
With respect to the analysis of the impact of 
outcome (dead or alive) on cost-of-care; mortality 
outcome, considered as an independent variable 
in a regression analysis, may have been subject to 
“endogenous variable bias”26. Hence the cost model 
was re-estimated using a treatment-effects model27, 
where specific allowance is made for the correlation 
of independent predictors and the error terms.
Further details of the statistical approaches are 
provided in Appendix 1 (see online version). Statistical 
significance was ascribed at the 0.05 level. Analyses 
were performed using the Stata™ statistical software 
(V10.1, 2008: Stata Corporation, College Station TX, 
USA). 
RESULTS
Demographics: patient characteristics and outcomes
During the study period, January 2000 through 
December 2005, there were 1617 patients aged <65 
years admitted into the ICU, 272 patients aged 
≥65 years admitted into ICU and 610 patients 
aged ≥65 years admitted to the hospital wards. The 
ISS of patients admitted to ICU, ≥65 years and 
<65 years of age, was not significantly different 
(P=0.29); but, not surprisingly, the ISS of elderly 
patients admitted to the ward was significantly lower 
(P=0.001). Both groups admitted to ICU were 
ventilated in similar proportions but not for the same 
time period (P=0.0004). Raw hospital mortalities 
for the groups created by the interaction of age- 
category×ventilation status were: ICU age <65 
years non-ventilated, 3.1%; ICU, age <65 years 
ventilated, 17.8%; ICU age ≥65 years non- 
ventilated, 11.3%; ICU age ≥65 years ventilated, 
61.5%; ward: age ≥65 years non-ventilated, 4.1%. 
A modest decline in the overall proportion of 
patients aged <65 years occurred over the time 
of the study, but not for the proportion ventilated 
(non-parametric trend test; P=0.014 and P=0.25 
respectively). A small decrease (1% per year) in 
mean ISS was also demonstrated over time (least 
squares regression, P=0.001). Additional patient 
demographics are shown in Table 1.
tabLe 1
Demographic and outcome details of patients in the three  
patient categories
Descriptor variable ICU: age 
<65 years 
ICU: age 
≥65 years
Ward: age 
≥65 years
n 1617 272 610
Age, y: mean (SD) 34.1 (13.6) 75.6 (7.1) 76.7 (7.8)
Gender (% male) 79.4 66.9 55.9
ISS: mean (SD) 21.3 (13.8) 21.7 (14.0) 8.3 (6.3)
Ventilator hours 
   n 770 122 N/A
   mean (SD) 114.4 (170.0) 157.9 (225.6) N/A
   median (IQR) 40 (129) 62 (181) N/A
Charlson index score
   0 1457 182 458
   1 114 58 93
   2 46 32 59
Length of stay 
   ICU (days)
      mean (SD) 4.5 (8.2) 4.8 (9.9) N/A
      median (IQR) 1.1 (5.3) 1.2 (4.9) N/A
   Hospital (days)
      mean (SD) 20.8 (28.8) 22.4 (26.6) 11.7 (15.2)
      median (IQR) 11 (21) 12.5 (24) 6.5 (12)
Mortality (%) 10.8 33.8 4.1
N/A=not applicable. The ISS score is the injury severity score 
derived from the sum of the squares of the three highest 
abbreviated injury scores (range 1-75).
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Hospital mortality outcome: logistic regression model
The data-set was not rich with potential 
predictors; the final model included (centred) 
calendar year as a linear continuous variable, ISS 
as a 0.5 fractional polynomial (see Appendix 1, 
“Statistical appendix” and Figure 1, left panel), CCI 
(scored 0, 1 and 2) and the interacted categorical 
predictors of [age-category×ventilation status]. 
The development set (n=1876) had an RoC area 
of 0.89; with P value for H-LĈ (=13.65) of 0.09. For 
the validation set (n=623), RoC area was 0.88 and 
H-LĈ=7.35, P=0.69. The variance inflation factor 
and condition number for the final model were 
2.74 and 12.9 respectively. Reported estimates 
were therefore generated on the whole data set 
(RoC area=0.89; and H-LĈ=17.9, P=0.02) and 
the parameters of the final model, point estimates 
(odds ratios [oR]) with P values and 95% confidence 
interval and variable chi-squared values are 
displayed in Table 2. As the logistic model was 
primarily discriminative-explanatory in intention, the 
relatively poor final calibration status of the whole 
data-set-model was accepted28.
Mortality oRs were increased with increases in 
CCI and over calendar years and decreased for all 
age×ventilation-status combinations compared with 
ventilated ICU patients, aged ≥65 years. Neither 
gender nor time(s) of admission demonstrated 
a mortality effect (P ≥0.2) and no significant 
interactions were demonstrated between 1) ISS 
tabLe 2
Parameter estimates of final logistic regression mortality model
Predictors oR P 95% CI: ll 95% CI: ul Chi-squared
Age <65 ICU, non-ventilated 0.014 0.0001 0.008 0.026 102.8
Age <65 ICU, ventilated 0.090 0.0001 0.055 0.148 45.4
Age ≥65 ICU, non-ventilated 0.061 0.0001 0.030 0.125 0.01
Age ≥65 ward, non-ventilated 0.086 0.0001 0.047 0.157 49.2
ISS: F-P 20.212 0.0001 13.318 30.676 329.8
Calendar year 1.127 0.008 1.032 1.230 0.5
CCI score 1 2.206 0.001 1.400 3.480 6.8
CCI score 2 2.567 0.001 1.448 4.549 5.1
CI=confidence interval, ll=lower limit, ul=upper limit, CCI=Charlson comorbidity index, 
ISS: F-P=parameter estimates for 0.5 fractional polynomial of ISS, oR=odds ratio.
Reference categories: age ≥65 years to ICU ventilated, CCI score 0; calendar year, centred.
figure 1: Left panel: Plot of ISS (horizontal axis) modelled as a (0.5) fractional polynomial against log odds ratio mortality (vertical axis) 
with 95% confidence interval. Right panel: Plot of ISS (horizontal axis) modelled as a (0.5, 3) fractional polynomial against log costs,  
2005 Australian dollars (vertical axis) with 95% confidence interval.
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tabLe 3
Mean daily (raw) cost per patient 
Descriptor Year n A$ costs
ICU current year ICU $ 2005 Hospital current year Hospital $ 2005
iCu <65 Years 2000 255 2124 2717 1436 1837
ICU ≥65 years 2000 53 2171 2777 1243 1590
Ward ≥65 years 2000 82 729 933
ICU <65 years 2001 278 2127 2694 1448 1834
ICU ≥65 years 2001 46 2436 3085 1071 1356
Ward ≥65 years 2001 77 724 917
ICU <65 years 2002 260 2409 2900 1743 2098
ICU ≥65 years 2002 40 2284 2750 1274 1534
Ward >65 years 2002 92 745 897
ICU <65 years 2003 259 2651 2940 1707 1893
ICU ≥65 years 2003 43 2630 2917 1883 2089
Ward ≥65 years 2003 92 773 857
ICU <65 years 2004 243 2747 2876 1771 1854
ICU ≥65 years 2004 38 2831 2964 1697 1777
Ward ≥65 years 2004 116 1020 1068
ICU <65 years 2005 322 3202 3202 1938 1938
ICU ≥65 years 2005 52 3086 3086 1914 1914
Ward ≥65 years 2005 151 1180 1180
Current year, cost as per each year. $ 2005, health CPI adjusted costs to calendar year 2005.
tabLe 4
Regression analysis of total costs (A$ 2005): log-transformed fractional polynomial (0.5, 3) model and treatment-effects model
FP model estimates Treatment effect estimates
Predictor  
variables
Coefficient 95% CI P % change* Coefficient 95% CI  
(lower, upper)
P % change*
Age <65 to ICU -0.191 -0.323, -0.059 0.0001 -17.6% -0.355 -0.502 ,-0.2070 0.0001 -29.9%
Age ≥65 to ward -0.764 -0.918, -0.610 0.0001 -53.6% -0.856 -1.016, -0.696 0.0001 -57.6%
Gender -0.096 -0.184,-0.008 0.033 -9.2% -0.096 -0.186, -0.007 0.035 -9.3%
Ventilation 0.189 0.097, 0.281 0.0001 20.7% 0.307 0.203, 0.410 0.0001 35.8%
ISS 1.740† 1.617, 1.863 0.0001 1.821† 1.693, 1.950 0.0001
-0.006† -0.007, -0.004 0.0001 -0.004 -0.006, -0.003 0.0001
CCI score 1 0.358 0.231, 0.485 0.0001 42.7% 0.391 0.261, 0.521 0.0001 47.5%
CCI score 2 0.809 0.636, 0.981 0.0001 123.6% 0.857 0.681, 1.034 0.0001 134.8%
outcome -0.988 -1.130, -0.846 0.0001 -62.9% -1.713 -2.020, -1.407 0.0001 -82.2%
Calendar year 0.024 0.002, 0.0462 0.034 2.4% 0.031 0.008, 0.053 0.008 3.1%
Cons 10.311 10.166, 10.456 0.0001
R2‡ 0.42 0.40
R2§ 0.22 0.20
Concordance 0.39 (0.36, 0.42) 0.42 (0.39, 0.45)
CI=confidence interval, ISS=injury severity score, CCI=Charlson comorbidity index, FP=fractional polynomial. Reference categories: 
age ≥65 years to ICU; female, not-ventilated; CCI=0; alive. * percentage change in dependent variable per unit change in the variable.  
† parameter estimates for the 0.5,3 fractional polynomial of ISS, % change not reported. R2‡=R2 estimated on the ‘log-dollar’ scale, R2 §=R2 
estimated on the ‘dollar’ scale. Concordance: concordance (95% CI)24 between predicted and raw costs (‘dollar’ scale).
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and mechanical ventilator status (P=0.30) or CCI 
(P=0.15) and 2) calendar year and age×ventilation-
status combinations (P ≥0.07). Further stratified 
outcomes are presented in Appendix 1, “Results, 
Hospital mortality model”.
Cost model
The cost patient cohort comprised 2499 patients, 
with overall mean cost of $28,811 (44,011) (median 
$13,394, range 263 to 496,850); A$ 2005 costs were: 
mean $36,331 (53,594), median $16,872 (range 336 to 
663,406). A trellis-plot of the total cost distribution 
(unadjusted for health CPI), by calendar year, over 
age-category by ventilation status is seen in Figure 2. 
Ventilated elderly patients sustained increased costs 
compared with the non-ventilated sub-cohorts and 
there were variable cost increments over the time 
period of the study. Average daily ICU and hospital 
costs, 2000 to 2005, are seen in Table 3. When 
adjusted for health CPI (‘A$ 2005’ costs), relatively 
modest and irregular increments occurred in both 
ICU and hospital costs. 
Covariate cost-effects from the log-cost regression 
analysis are seen in Table 4. Statistical advantage 
for modelling the effect of ISS by a fractional 
polynomial (0.5, 3; Figure 1, right panel) was 
demonstrated in the determination set (R2=0.42) 
and the polynomial effect as (0.5, 3) was sustained 
in the validation set (R2=0.41); final coefficients 
were reported for the whole data set (R2=0.42; 
Table 5). A small (2.4%) yearly cost increment 
was evident; the year effect being modelled as a 
tabLe 5
Mean total raw and predicted costs (A$ 2005) by calendar year and age category
Year Raw costs
ICU: age <65 years ICU: age ≥65 years Ward: age ≥65 years
Alive Died Alive Died Alive Died
2000 36703 37863 39073 32295 12045 12447
2001 49896 34986 52567 19191 12885 13513
2002 48908 42198 49864 53153 14566 5205
2003 48471 25604 39097 27242 15042 4347
2004 41678 27451 62270 26507 10983 2888
2005 46674 27151 48903 26484 13111 10829
Year FP log cost model
ICU: age <65 years ICU: age ≥65 years Ward: age ≥65 years
Alive Died Alive Died Alive Died
2000 46774 27706 51660 41578 12791 5380
2001 47915 30331 55281 37449 14425 12683
2002 48691 35543 49751 33700 15099 9291
2003 43451 27589 49021 35427 14004 9679
2004 42084 27423 67563 26598 10440 11009
2005 52164 27440 70996 36534 13142 12272
Year Treatment effects model
ICU: age <65 years ICU: age ≥65 years Ward: age ≥65 years
Alive Died Alive Died Alive Died
2000 49339 29129 55705 40169 13231 7208
2001 50147 32102 59908 34606 14894 13457
2002 50859 35250 54056 32066 15621 11021
2003 45444 28591 52307 33048 14430 10584
2004 43958 28980 71334 26459 10856 11454
2005 54232 29152 70548 32922 13678 12601
FP=fractional polynomial model (see Table 4).
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linear continuous variable, there being no 
evidence of non-linearity. No interaction between 
calendar year and categorical variables, nor 
between categorical variables was apparent 
(P ≥0.59). On the ‘dollar’ scale, the final R2 of 
the log-cost model was 0.22. As expected, the log 
cost model was superior to the raw cost model in 
terms of residual analysis and the concordance of 
predicted and raw costs was superior (0.39 vs 
0.32, respectively). Further details of cost model 
development are provided in Appendix 1, “Results, 
Cost model”.
Mean overall difference between those alive 
and dying, for raw and predicted (A$ 2005) costs 
(fractional polynomial log-cost model), was estimated 
at $7688 and $9841 respectively. In the treatment-
effects model (Table 4), modest changes occurred 
in the parameter estimates compared with the 
fractional polynomial model, with the difference 
in the percentage change for the outcome effect 
(dead vs alive) being 19.3% (-82.2% vs -62.9%, 
respectively). The treatment-effects model was well 
specified with respect to residual analysis and there 
was minimal evidence of heteroscedasticity (non- 
constant variance; see also Appendix 1, “Results, 
Cost model”). Mean overall difference, alive vs dead, 
was $11,142 (A$ 2005).
Mean cost comparisons (alive vs died, estimated 
for baseline categories (Table 4), A$ 2005), for 
fractional polynomial least squares regression versus 
treatment-selection model and referenced to raw 
cost, over calendar year and between age categories, 
are seen in Table 5. Predicted costs for surviving 
patients generally exceeded cost for those dying 
and the differential was increased for the treatment 
-effects model. Cumulative differences, alive vs died, 
over year and age categories, were: raw costs, 
$213,382; fractional polynomial model, $257,620; 
and treatment-effects model, $291,748.
DISCUSSIoN
Mortality outcome
The adverse impact of age upon mortality-
outcome7,29 was confirmed in the current study of 
elderly patients admitted into intensive care. The 
observed mortality rate observed was consistent with 
the findings of the recent National Trauma Registry, 
with an estimated 30% elderly mortality at hospital 
discharge following a major trauma (ISS >15), 
and with reports published in North America and 
Europe. Despite higher mortality rates in the elderly 
compared with the younger age group, these rates 
were comparable with other disease outcomes such 
as severe sepsis30.
In agreement with the Major Trauma outcome 
Study (MToS), ISS increments were associated 
with increased mortality31, which was not a linear 
function of the ISS (Figure 1), a finding similar to 
the modelled effect of the acute physiological and 
chronic health evaluation III score on mortality 
outcome32. The injury severity score has proved 
popular over time despite deficiencies when there 
is more than one injury per body system. More 
insightful would have been a detailed breakdown of 
the injury severity scores to that of individual body 
systems and analysis of the relationship with overall 
mortality. It has been shown that head injury in 
the elderly, compared with younger patients, is 
associated with decreased surgical intervention and 
higher mortality33; similarly, rib fractures are also 
associated with increased risks of death34. Further 
studies are needed to look at the differential impact 
of specific organ injuries on the management and 
survival of the elderly.
The impact of CCI on prognosis in the spectrum 
of critically ill patients has been variable35. The 
limited range of the CCI scores observed in the 
current study were in general agreement with 
Gabbe et al36 and may have simply represented the 
characteristics of the cohort of elderly patients; 
that is, those in better health, being of increased 
mobility, were more likely to suffer from trauma. of 
interest, ‘coagulopathy’, which may be important in 
the trauma setting, does not contribute to the CCI 
components37. The number of patients prescribed 
anticoagulants in Australia is increasing at a yearly 
rate of 9%38. It is possible that over the ensuing 
years, with the increase use of antiplatelet therapy 
and anticoagulants, bleeding risks in this cohort of 
trauma patients will increase significantly and have 
greater impact on outcomes.
A requirement for artificial ventilation predicted 
mortality (Table 2) and in the age category ≥65 
years, the ventilation hours were also notably longer. 
Mechanical ventilation is known to be a predictor of 
mortality in various other disease states, more so in 
the elderly39. Gender, on the other hand, had no 
demonstrable effect on survival in our study. While 
experimental data seem to support the influence of 
gender on disease processes, with the female gender 
conferring benefit, clinical evidence in trauma 
patients has been conflicting40. The reasons for the 
modest mortality increment over time were not 
immediately obvious, there being no significant 
interaction between calendar year and the 
age×ventilation-status combinations (see “Results, 
Hospital mortality outcome: logistic regression 
model” above) and the ISS demonstrated a small 
decrease with time. The most plausible explanation 
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would appear to be the decrease in the overall 
proportion of patients aged <65 years over the study 
period.
Costs
A ‘top-down’ costing of care was used as a broad 
assessment of resource utilisation. There were 13 
identified cost-buckets that encompassed both cost 
not directly related to the individual patient care 
(but necessary for daily maintenance of services) 
and that which was directly related to cost incurred 
in care. This method, though not standardised across 
hospitals in Australia, has been advocated and 
applied in other studies as a means to uniformly 
define and compare ICU expenditure12,41. While 
data on ICU trauma costing is scarce, this study has 
revealed some interesting comparisons. The total 
and average daily cost of care for patients in the 
ICU age categories were comparable with other 
Australian studies. Rechner et al and Moran et al 
found that the average daily costs of ICU treatment 
were $2670 (calendar years 2002 to 2003) and $2395 
(calendar year 2002) respectively11,12. The overall 
(2000 to 2005) mean daily treatment costs in our 
study were similar (Table 3), albeit the acquisition 
of treatment cost were calculated differently. The 
significant cost contributors, for example, drugs, 
pathology and radiology noted by Rechner et al 
were not included in the ICU costing (see Appendix 
2 on the online version) but were instead factored 
into the ‘total hospital bill’. Trauma patients would 
have incurred much higher operating theatre cost, 
once again captured only in the total hospital cost. 
In Australia, blood transfusion is funded by the 
Australian Red Cross, trauma patients being a major 
consumer, and this may have under-estimated cost 
when compared with other jurisdictions. Although 
international comparisons may reflect different 
treatment-cost acquisition, the above reported costs 
would appear to be less than the US$ (2004) daily 
ICU cost of $2575 (≡A$3420) reported by Milbrandt 
et al23. of interest, the latter authors reported stable 
ICU daily costs over the period 1994 to 2004, whereas 
the present study, albeit in trauma patients, found 
an annual increment (in A$ 2005) of 2.4%, against 
a background of an annual increase in ICU length 
of stay of 0.83%.
The factors that increased mortality were also 
those factors that increased the cost of care, while 
‘death’ in itself somewhat paradoxically limited 
further escalation of cost, although the interaction 
between ‘outcome’ and ‘Age-category’ was non- 
significant (global Wald test, P=0.31). This 
observation differs from that found by Seguin et 
al, where total expenditure on non-survivors was 
greater42.
Critique of methodology
The current study derived its patient cohort and 
cost-structure from a single tertiary referral centre, 
and obviously inferences may not be relevant to other 
jurisdictions. Although long-term follow-up was not 
established, the restriction of follow-up to hospital 
discharge was of advantage in that a correspondence 
was established between variables predicting 
(hospital) outcome and costs. Long-term functional 
outcomes, increasingly recognised as meaningful 
outcome measures, were also not measured. 
Intensive care obviously serves the acute-care 
environment, but it is appropriate that the cost 
of protracted rehabilitation, any decrement in 
quality of life and other social-economic costs be 
considered in the period that follows ‘successful’ 
intensive care. Age has always been modelled in 
health economics as having higher impact upon 
future cost. This supposition has been recently re- 
assessed with the demonstration that the time-period 
proximate to death is the period of substantive cost 
escalation (ICU care being a part thereof)43.
The final cost model had an R2 on the dollar scale 
of 0.22, which was modest, but comparable with 
other studies and overviews11,44,45. The mortality effect 
of outcome on cost in the log-cost least squares 
model was biased upwards (-62.9% vs -82.2%) with 
respect to that of the treatment-effects model, which 
addressed the endogeneity of ‘outcome’ in the least 
squares regression (identified by the correlation of 
the error terms of the separate determination of costs 
and outcome in the treatment-effects regression; 
see Appendix 1 on the online version). This approach 
may thus be preferred when binary endogenous 
‘outcome’ variables are used as independent 
regression variables46,47; an analytic direction 
previously comment upon39. This being said, the 
overall predicted cost difference, alive versus dead, 
between the two approaches was modest (Table 5). 
CoNCLUSIoN
Those factors decreasing survival time were also 
associated with cost increments, although mortality 
per se was associated with an overall cost decrease. 
Costs increased minimally over the calendar year 
span of the study. Cost methodology must 
appropriately address endogenous variable bias.
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